ExodusPoint Capital Management, LP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$252
-57.3%
12,938
-35.9%
0.00%
-77.8%
Q4 2022$590
-100.0%
20,199
-45.6%
0.01%
-55.0%
Q2 2022$1,649,000
+138.6%
37,111
+124.2%
0.02%
+100.0%
Q1 2021$691,000
+98.0%
16,554
+120.9%
0.01%
+233.3%
Q4 2020$349,0007,4950.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders